Jamie Fung
Acute Care · Portland, ORNPI 1619747557
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 38.4% of the total. Among acute care clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 92 payments — averaging $22.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$810
- Pfizer$280
- Abbott$212
- Lilly USA, LLC$104
- Merz Pharmaceuticals, LLC$59
- Bayer$52
- plus $592 from 24 others
What the payments were for
- Food & beverage$2,110100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $810 |
| Pfizer | 17 | $280 |
| Abbott | 5 | $212 |
| Lilly USA, LLC | 4 | $104 |
| Merz Pharmaceuticals, LLC | 3 | $59 |
| Bayer | 3 | $52 |
| Amneal Pharmaceuticals LLC | 2 | $48 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| CSL Behring | 2 | $41 |
| Painteq LLC | 1 | $39 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| Nevro Corp. | 1 | $31 |
| Acadia Pharmaceuticals Inc | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Nalu Medical, Inc. | 1 | $24 |
| EMD Serono, Inc. | 1 | $22 |
| Organon | 2 | $21 |
| Vertex | 1 | $20 |
| Si-bone, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Saluda Medical Americas, Inc. | 1 | $17 |
| Sanofi | 1 | $17 |
| UCB, Inc. | 1 | $17 |
| Viiv Healthcare Company | 1 | $17 |
| Vertos Medical, Inc. | 1 | $17 |
| Avanos Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,110 in reported general payments places this provider in the 90th percentile of 105 acute care providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 38 | $783 |
| Diazepam | 18 | $44 |
Paid to pharmacies, not to this prescriber.
Other acute care in Portland
- Robin MillerPortland$74K
- Jacqueline TrussellPortland$15K
- Lina Rossetti-GrulichPortland$8K
- Aura PetcuPortland$3K
- Amy AlbertsPortland$2K
- Lynzy Elzinga WeekesPortland$2K
- Benjamin HartwigPortland$1K
- Kristyn DemelloPortland$1K
- Dana MoussalliPortland$1K
- Melissa SkinnerPortland$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.